Loading...
NewGenIvf Group Ltd (NIVF) is not a good buy for a beginner investor with a long-term focus. The company's financial performance is significantly deteriorating, with sharp declines in revenue, net income, EPS, and gross margin. Technical indicators show a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, the stock is projected to decline in the short and medium term, making it unsuitable for a long-term investment strategy.
The MACD histogram is positive but contracting, indicating weakening momentum. The RSI is neutral at 20.398, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S1 support level of 0.765, with resistance levels at 1.361 and 1.545. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The company's financial performance has deteriorated significantly, with sharp declines in revenue (-12.94% YoY), net income (-84822.54% YoY), EPS (-2093.67% YoY), and gross margin (-79.11% YoY). Technical indicators are bearish, and the stock is projected to decline in the short and medium term.
In 2025/Q3, the company reported a revenue drop of -12.94% YoY to 1,282,251. Net income plummeted by -84,822.54% YoY to 16,823,355. EPS fell by -2093.67% YoY to 195.38, and gross margin dropped by -79.11% YoY to 9.2. These figures indicate severe financial underperformance.
No data on analyst ratings or price target changes is available.
